Home › Identities › Transmasculine

Transmasculine

Transmasculine is a euphemistic intermediate layer — a broader umbrella than trans man, avoiding the sharp claim "I am a man" and capturing larger groups. It makes numbers larger and the evidence base weaker. A creed packaged as spectrum jargon, resulting in testosterone and mastectomy for adolescent girls.

Definition according to proponents

Someone who was registered as female at birth and identifies somewhere on a masculine spectrum — not necessarily as a full man. The umbrella also covers butch presentation, non-binary masculine self-identification, and partial transgender claims.

Origin: ROGD cohort 2010+

The term came into use starting in the 2010s and has gained significant ground since 2018, partly because clinics and activism sought to group larger groups under one umbrella. In the ROGD cohort, a majority prefers to call themselves transmasculine rather than trans man.

Michael Biggs (2022) has documented for the UK that between 2010 and 2020, the number of registrations of birth girls at gender clinics increased by a factor of 30–50, while the number of registrations of birth boys hardly changed. Lisa Littman (2018) documented clustering of such registrations within friendship circles and intensive social media use as a shared history. The Cass Review (2024) confirms this demographic signal and points out the absence of robust explanations from the affirmative school. See spread since 2010 .

Criticism: spectrum management hides subgroups

Transmasculine does what an umbrella term does: inflates statistics without the subgroups being empirically comparable. A 14-year-old girl with TikTok self-promotion and a 45-year-old woman with lifelong dysphoria fall under the same label. Policy and publications treat them as one group. There is no marker , only self-reporting — a textbook example of circular reasoning and unfalsifiability .

This "spectrum management" does not solve clinical problems but obscures them. See Cass Review and desistance research . Stock (2021) and Joyce (2021) point out the underlying philosophical premise: as soon as "identity" counts as a categorization criterion, fundamentally different biological realities can be grouped under one name. Levine (2022) warns clinicians that without distinction, informed consent for irreversible procedures—testosterone, mastectomy—cannot meet standard norms. Anyone who points out the difference is silenced and dismissed as a hater or transphobe.

Hruz (2020) summarizes the evidence base: for adolescent women with recently developed transmasculine self-identification, there is a lack of validated research supporting hormones or surgery as evidence-based treatment. SBU (2022) and NICE (2020) reach the same conclusion. Detransition data from Littman (2021) and Vandenbussche (2021) point to substantial minority percentages of regret and reversal, precisely within this subgroup.

Damage: testosterone and mastectomy in healthy girls

Cass explicitly recommends that clinical pathways for minors under the transmasculine umbrella be offered only within formal research protocols, given the lack of long-term outcomes. Mastectomy on healthy breast tissue in minors is no longer recommended as routine by SBU (2022) and the Finnish guideline (2020). Transition does not cure — see detransition research and regret research .

Related identities

• Transman — scarier claim.

• Demigender — partial claim.

• Non-binary — umbrella.

• Transgender — broad umbrella.

Frequently Asked Questions